RecruitingPhase 2NCT04623931
Rare condition
Oligoastrocytoma
3
studies recruiting now
as of 7 Sept 2026
91
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
11 Jun 2021
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT02800486
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
RecruitingPhase 1 / Phase 2NCT04923126
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Oligoastrocytoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Oligoastrocytoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Oligoastrocytoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (IDH2).
Treatments being studied
4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Temozolomide (Temodal)
Phase 2Talampanel
Phase 2Palbociclib (Ibrance)
Phase 1 (early)Hiltonol
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).